Loading...
Eribulin mesylate in the treatment of metastatic breast cancer
The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are approved for the therapy of MBC, there is no standard approach for therapy beyond the second-line. Eribulin me...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3266863/ https://ncbi.nlm.nih.gov/pubmed/22291464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S19811 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|